Results 231 to 240 of about 1,177,456 (242)

Nintedanib Plus Sildenafil in Patients With Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2018
Ganesh Raghu, Luca Richeldi, Fernando J Martinez   +2 more
exaly  

Familial Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 1986
Ronald Crystal, Stephen I Rennard, Mark D Wewers   +2 more
exaly  

A Variant in the Promoter of MUC5B and Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2011
Naftali Kaminski, Yingze Zhang, Imre Noth   +2 more
exaly  

Collagenase in the Lower Respiratory Tract of Patients With Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 1979
Ronald Crystal, Jack D Fulmer, J D Fulmer   +2 more
exaly  

Antioxidant Therapy for Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2005
Gary W Hunninghake
exaly  

A New Hope for Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2014
Gary M Hunninghake
exaly  

A Phase 3 Trial of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2014
David J. Lederer, Lisa Lancaster, Jeffery Swigris   +2 more
exaly  

A Preliminary Study of Long-Term Treatment With Interferon Gamma-1b and Low-Dose Prednisolone in Patients With Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 1999
Ventzislav Petkov, R Ziesche, Rolf Ziesche   +2 more
exaly  

Forced Vital Capacity in Idiopathic Pulmonary Fibrosis — FDA Review of Pirfenidone and Nintedanib

New England Journal of Medicine, 2015
Badrul A Chowdhury
exaly  

Revealing the Secrets of Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2019
David A Schwartz, Richard K Albert
exaly